University of Utah Healthcare
Salt Lake City, Utah 84132
10 studies enrolling now · 32 studies all time
What they study most
Acute Ischemic Stroke, Atrial Fibrillation, Atrial Flutter, Bleeding, Brain Injuries, Traumatic, CPAP, Cerebral Infarction, Congenital Heart Disease, Constipation, Covid19, Crohn's Disease, Eosinophilic Esophagitis (EoE)
Studies at this site
- Dynamic Critical Congenital Heart Screening With Addition of Perfusion Measurements — Recruiting now
- Pain Relief After Trapeziectomy: Ibuprofen & Acetaminophen Versus Oxycodone — Recruiting now
- Strategy for Improving Stroke Treatment Response — Recruiting now
- A Study to Evaluate Efficacy and Safety of an Investigational Drug Named Volixibat in Patients With Itching Caused by Primary Biliary Cholangitis — Recruiting now
- Ketamine add-on Therapy for Established Status Epilepticus Treatment Trial (KESETT) — Recruiting now
- Anticoagulation in ICH Survivors for Stroke Prevention and Recovery — Recruiting now
- A Study to Assess the Effectiveness and Safety of Pacritinib in Patients With VEXAS Syndrome (PAXIS) — Recruiting now
- Recombinant Factor VIIa (rFVIIa) for Hemorrhagic Stroke Trial - Part 2 — Recruiting now
- StrokeNet Thrombectomy Endovascular Platform — Recruiting now
- Validation of Early Prognostic Data for Recovery Outcome After Stroke for Future, Higher Yield Trials — Recruiting now
- RNS System NAUTILUS Study — Completed
- Brain Oxygen Optimization in Severe TBI, Phase 3 — Running, not enrolling
- A Study to Evaluate Efficacy and Safety of an Investigational Drug Named Volixibat in Patients With Itching Caused by Primary Sclerosing Cholangitis (PSC) — Running, not enrolling
- Sleep for Stroke Management and Recovery Trial — Running, not enrolling
- Recombinant Factor VIIa (rFVIIa) for Hemorrhagic Stroke Trial — Running, not enrolling
- Improving the Quality of Care for Adults With Inflammatory Bowel Disease — Enrolling by invitation
- Multi-arm Optimization of Stroke Thrombolysis — Completed
- Glyburide Advantage in Malignant Edema and Stroke - Remedy Pharmaceuticals — Completed
- Pomalidomide for the Treatment of Bleeding in HHT — Completed
- Exploring Safety & Clinical Benefit of Anti-Influenza Immunoglobulin Intravenous in Hospitalized Adults With Influenza A — Completed
- A Study to Evaluate the Efficacy and Safety of CC-90001 in Subjects With Idiopathic Pulmonary Fibrosis — Stopped early
- Phase ll Study of Pirfenidone in Patients With RAILD (TRAIL1) — Completed
- Convalescent Plasma in Outpatients With COVID-19 — Completed
- OBS in Adolescent and Adults With EOE: A Phase II, Randomized, Double-Blind, Placebo Controlled, Study With an Open Label Extension — Completed
- Efficacy and Safety of Riociguat in Patients With Systemic Sclerosis — Completed
- High Volume Lactated Ringer's Solution and Pancreatitis — Stopped early
- A Randomized Controlled Trial of Eculizumab in AQP4 Antibody-positive Participants With NMO (PREVENT Study) — Stopped early
- Endovascular Therapy Following Imaging Evaluation for Ischemic Stroke 3 — Stopped early
- Prospective Genotyping For Total Hip or Knee Replacement Patients Receiving Warfarin (Coumadin) — Completed
- Ease of Use, Tolerability, Efficacy and Safety of the Vibrant Capsule Administered in the Home Environment — Withdrawn before enrolling
- Safety and Feasibility Trial of Adipose-Derived Regenerative Cells in the Treatment of Chronic Myocardial Ischemia — Completed
- Clarification of Optimal Anticoagulation Through Genetics — Completed